# Obeticholic Acid in Bile Acid Diarrhoea

> **NCT01585025** · PHASE2 · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 35 (actual)

## Conditions studied

- Primary Bile Acid Malabsorption
- Secondary Bile Acid Malabsorption
- Chronic Diarrhoea

## Interventions

- **DRUG:** Obeticholic acid

## Key facts

- **NCT ID:** NCT01585025
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01585025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01585025, "Obeticholic Acid in Bile Acid Diarrhoea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01585025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*